- November 3, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
N/A
Synonyms :
benorilate
Class :
Antipyretics, Non-Opioid Analgesics
Dosage Forms & Strengths
Tablet
2g
4g
6g
Administer 2g twice a day.
Do not exceed 6g in a day.
Analgesia
Administer 2g twice a day.
Osteoarthritis
Administer 2g twice a day.
Safety and efficacy not established
Refer adult dosing
may increase the risk of adverse effects when combined
may increase the risk of adverse effects when combined
may increase the risk of adverse effects when combined
may increase the risk of adverse effects when combined
may increase the risk of adverse effects when combined
may increase the risk of adverse effects when combined
may diminish the excretion rate of amantadine
may increase the risk of hypertension when combined
When benorilate is used together with hexoprenaline, the potential for hypertension to occur may be elevated
may increase the risk or severity of hypertension when combined
Actions and Spectrum:
It has a unique mechanism of action that involves the simultaneous release of both aspirin and paracetamol when metabolized in the body. The exact mechanism of action of benorilate is not fully understood, but its active metabolites, aspirin and paracetamol, exert their effects through different pathways:
aspirin (acetylsalicylic acid):
paracetamol (acetaminophen):
Spectrum of Activity:
benorilate’s spectrum of activity is like that of aspirin and paracetamol.
Frequency not defined
GI disturbances
Hypersensitivity reactions
Tinnitus
Heartburn
Drowsiness
Dizziness
Deafness
Black box warning:
None
Contraindications/caution:
Contraindications:
Pregnancy consideration: benorilate is not recommended during pregnancy, especially in the last trimester, as it can affect the baby’s circulation and cause other complications.
Lactation: It should also be avoided during breastfeeding because aspirin and its metabolites can pass into breast milk.
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacodynamics:
Combining aspirin and paracetamol in benorilate provides a synergistic effect, resulting in a broader spectrum of pain relief than either component alone.
The anti-inflammatory effects of aspirin complement the analgesic effects of paracetamol, making benorilate effective for conditions with both pain and inflammation, such as arthritis.
Pharmacokinetics:
Absorption
benorilate is administered orally as a tablet or capsule. The absorption of benorilate occurs in the gastrointestinal tract after oral administration. aspirin and paracetamol, the active components of benorilate, are readily absorbed through the intestinal lining and enter the bloodstream.
Distribution
Once absorbed into the bloodstream, aspirin, and paracetamol are distributed throughout the body. Both aspirin and paracetamol have relatively high-water solubility, allowing them to distribute into various tissues and organs.
Metabolism
In the body, benorilate undergoes metabolic processes that release its active components, aspirin, and paracetamol. aspirin is hydrolyzed to salicylic acid, its active form. Salicylic acid is metabolized in the liver via conjugation to form various metabolites, mainly salicyluric acid and salicyl phenolic glucuronide. paracetamol is metabolized in the liver by conjugation with glucuronic acid and sulfate to form inactive metabolites, which are then excreted in the urine.
Elimination and Excretion
The elimination of benorilate and its metabolites occurs mainly via the renal (urinary) route. The metabolites of aspirin (salicyluric acid and salicyl phenolic glucuronide) are eliminated primarily in the urine. The metabolites of paracetamol (glucuronide and sulfate conjugates) are also excreted in the urine.
Administration:
Oral administration
Take benorilate with food or immediately after meals.
Patient information leaflet
Generic Name: benorilate
Why do we use benorilate?
benorilate is a medication that combines aspirin (acetylsalicylic acid) and paracetamol (acetaminophen). It was primarily used for its analgesic and anti-inflammatory properties. Here are some of the common uses of Benorilate: